help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Courtin, F.
Right arrow Articles by Pierre, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Courtin, F.
Right arrow Articles by Pierre, M.

Endocrinology, Vol 125, 1277-1281, Copyright © 1989 by Endocrine Society


ARTICLES

Induction of type II 5'-deiodinase activity in cultured rat astroglial cells by 12-O-tetradecanoylphorbol-13-acetate: dependence on glucocorticoids

F Courtin, F Chantoux, JM Gavaret, D Toru-Delbauffe, C Jacquemin and M Pierre
Unite de Recherche sur la Glande Thyroide et la Regulation Hormonale (U.96) de l'Institut National de la Sante et de la Recherche Medicale, Le Kremlin-Bicetre, France.

The effect of an activator of protein kinase C, 12-O- tetradecanoylphorbol-13-acetate (TPA), on the 5'-deiodinase (5'D) activity was studied in rat astroglial cells cultured in chemically defined medium. TPA promoted a large increase in the type II 5'D activity, which was maximal 5-10 h after addition of TPA and then declined to the basal level at 24 h. The optimal TPA concentration was 10(-7) M. TPA and 8-Br-cAMP, an other inducer of 5'D activity were antagonist. Otherwise, TPA stimulated 5'D activity only in the presence of glucocorticoids at concentrations from 10(-8) M to 10(-4) M. Glucocorticoids alone induced a slight increase in 5'D activity. These data indicate that protein kinase C contributes to the control of 5'D activity in astroglial cells and that its action is dependent on glucocorticoids.


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Lamirand, S. Pallud-Mothre, M. Ramauge, M. Pierre, and F. Courtin
Oxidative Stress Regulates Type 3 Deiodinase and Type 2 Deiodinase in Cultured Rat Astrocytes
Endocrinology, July 1, 2008; 149(7): 3713 - 3721.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Lamirand, G. Mercier, M. Ramauge, M. Pierre, and F. Courtin
Hypoxia Stabilizes Type 2 Deiodinase Activity in Rat Astrocytes
Endocrinology, October 1, 2007; 148(10): 4745 - 4753.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. G. Trentin
Thyroid hormone and astrocyte morphogenesis.
J. Endocrinol., May 1, 2006; 189(2): 189 - 197.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. Araki, T. Morimura, T. Ogiwara, H. Mizuma, M. Mori, and M. Murakami
Expression of Type 2 Iodothyronine Deiodinase in Corticotropin-Secreting Mouse Pituitary Tumor Cells Is Stimulated by Glucocorticoid and Corticotropin-Releasing Hormone
Endocrinology, October 1, 2003; 144(10): 4459 - 4465.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. W. Li, C. Le Goascogne, M. Ramauge, M. Schumacher, M. Pierre, and F. Courtin
Induction of Type 3 Iodothyronine Deiodinase by Nerve Injury in the Rat Peripheral Nervous System
Endocrinology, December 1, 2001; 142(12): 5190 - 5197.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Murakami, O. Araki, T. Morimura, Y. Hosoi, H. Mizuma, M. Yamada, H. Kurihara, S. Ishiuchi, M. Tamura, T. Sasaki, et al.
Expression of Type II Iodothyronine Deiodinase in Brain Tumors
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4403 - 4406.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T. Bartha, S.-W. Kim, D. Salvatore, B. Gereben, H. M. Tu, J. W. Harney, P. Rudas, and P. R. Larsen
Characterization of the 5'-Flanking and 5'-Untranslated Regions of the Cyclic Adenosine 3',5'-Monophosphate-Responsive Human Type 2 Iodothyronine Deiodinase Gene
Endocrinology, January 1, 2000; 141(1): 229 - 237.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S.-W. Kim, J. W. Harney, and P. R. Larsen
Studies of the Hormonal Regulation of Type 2 5'-Iodothyronine Deiodinase Messenger Ribonucleic Acid in Pituitary Tumor Cells Using Semiquantitative Reverse Transcription-Polymerase Chain Reaction
Endocrinology, December 1, 1998; 139(12): 4895 - 4905.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Guadano-Ferraz, M. J. Obregon, D. L. St. Germain, and J. Bernal
The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain
PNAS, September 16, 1997; 94(19): 10391 - 10396.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Pallud, A.-M. Lennon, M. Ramauge, J.-M. Gavaret, W. Croteau, M. Pierre, F. Courtin, and D. L. St. Germain
Expression of the Type II Iodothyronine Deiodinase in Cultured Rat Astrocytes Is Selenium-dependent
J. Biol. Chem., July 18, 1997; 272(29): 18104 - 18110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society